You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Quieting of Continuous Miner Scrubber Fan Noise

    SBC: AVEC INC            Topic: NIOSH

    DESCRIPTION (provided by applicant): This proposal targets a specific mission of NIOSH and the current SBIR solicitation: hearing loss prevention for mine workers. The main objective of this work is to reduce the noise radiated by Continuous Miners (CM). Since CMs are responsible for about 30% of noise exposures above permissible levels [MSHA, 2006], reducing the noise in this machine would have a ...

    SBIR Phase I 2012 Department of Health and Human ServicesCenters for Disease Control and Prevention
  2. The Remote Brief Intervention and Referral to Treatment service for Alcohol (R-BI

    SBC: POLARIS HEALTH DIRECTIONS, INC            Topic: NIAAA

    DESCRIPTION (provided by applicant): Although the USPHSTF, SAMHSA, the CDC, and NIAAA have affirmed the central role that healthcare providers play in screening, brief intervention, and referral to treatment (SBIRT) for alcohol abuse, translation of theserecommendations to clinical practice continues to be elusive. To address this problem, Polaris Health Directions (Small Business) and the Univers ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  3. Point-of-Care Diagnostic Test for Entamoeba histolytica Cysts

    SBC: TECHLAB, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The NIAID Category B priority pathogen Entamoeba histolytica is a public health threat, especially as a cause of diarrhea in travelers to and immigrants from endemic areas, men who have sex with men, and children in thedeveloping world where it is in the top 5 causes of severe diarrhea. It is also a biodefense threat to water and food supplies due to its resist ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Targeted Imaging Mass Spectroscopy for Biomarker Detection in Human Tissues

    SBC: PROVIA BIOLOGICS LIMITED LIABILITY COMPANY            Topic: NCI

    DESCRIPTION (provided by applicant): Biomarkers are measured in patient tissue biopsies to refine diagnosis, and to guide therapy. For a patient, this means receiving the therapy or drug most likely to work while avoiding the expense and toxic side effectsof alternatives. In pathology, a long-standing problem is that the most accurate methods for biomarker detection in tissues require extraction a ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Design of a real-time dosimetry prototype for use with external beam radiotherapy

    SBC: Best Medical International, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): Radiation oncology patients receive highly complicated treatments such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy, stereotactic radiosurgery and stereotactic body radiation therapy using clinical linear accelerators. Currently, the quality assurance (QA) of a radiation treatment is don a priori to measure cumulative doses ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Microfluidic Processing of Leukocytes for Molecular Diagnostic Testing

    SBC: GPB Scientific, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): Microfluidic Processing of Leukocytes for Diagnostics Testing Summary/Abstract: New tests to quantify the numbers and functional states of key leukocyte types from blood samples offer enhanced determination and personalization of clinical diagnosis, prognosis, and treatment response. For example, labeling of gt30 cell surface and intracellular target molecules ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Bacterially-Secreted GLP-1 Induced Reprogramming of Intestinal Cells as a Treatme

    SBC: BIOPANCREATE, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): The product that will result from the proposed SBIR program, a consortium collaboration between BioPancreate (a small business) and Cornell University, will be an orally-administered insulin-replacement therapy for bothtype-1 and type-2 diabetes mellitus, utilizing a novel live biotherapeutic product that reprograms host intestinal stem cells into pancreatic ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Development of website devoted to legal issues associated with medical research

    SBC: IP ADVANTAGE            Topic: NIGMS

    DESCRIPTION (provided by applicant): There is a clear lack of needed information geared towards investigators and other clinical trial professionals on the legal/regulatory aspects of clinical trials. While keeping up with regulatory changes related to clinical trials is challenging staying abreast of other areas of the law which do not immediately come to mind when thinking about clinical trials ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  9. High Efficiency Microfluidic Purification of Stem Cells to Improve Transplants

    SBC: GPB Scientific, Inc.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Hematopoietic stem-progenitor cell (HSPC) transplantation is an established therapy for many malignant and non-malignant diseases. HSPCs are harvested clinically from 3 sources: G-CSF mobilized adult peripheral blood (PBSC), bone marrow (BM), and umbilical cord blood (UCB). Because erythrocytes increase both the risk of harmful side effects in transplant patien ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Mitochondrial DNA repair agents for acute lung injury

    SBC: EXSCIEN CORPORATION            Topic: NHLBI

    DESCRIPTION (provided by applicant): Drug development for acute lung injury (ALI) has been marred by unfulfilled expectations. Perhaps best illustrating this unsatisfactory situation is the history of therapeutic strategies directed at inhibition of reactive oxygen species (ROS). While decades of laboratory and clinical studies make it clear that ROS are pathogenically important across the entire ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government